C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
11/2002
11/27/2002	EP1259493A2 Substituted piperazine compounds
11/27/2002	EP1259492A1 Substituted piperazine derivatives as mtp inhibitors
11/27/2002	EP1153050A4 Amino-ketone solid support templates
11/27/2002	EP0862557B1 SYMMETRICAL bis-HETEROARYLMETHOXYPHENYLALKYL CARBOXYLATES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS
11/27/2002	CN1382136A N-heterocyclic derivatives as NOS inhibitors
11/27/2002	CN1094930C Quinoxaline and preparation method and application thereof
11/26/2002	US6486165 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/26/2002	CA2055174C Process for the synthesis of alpha-((dialkylamino) substituted-methylene)-beta-oxo-(substituted) propanenitriles
11/22/2002	WO2001090079A2 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
11/22/2002	CA2410304A1 Novel carbamates and ureas production and use thereof as endothelin receptor antagonists
11/21/2002	US20020173500 Hypotensive agents; antiischemic agents
11/21/2002	US20020173488 Boronic Ester and acid compounds, synthesis and uses
11/21/2002	US20020173469 Protease inhibitors
11/20/2002	EP1257536A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/20/2002	CN1094489C Process for producing pyrazine compounds
11/19/2002	US6482951 Isoindolin-1-one glucokinase activators
11/19/2002	US6482834 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
11/19/2002	US6482438 Apparatus and process for preparing crystalline particles
11/19/2002	CA2044143C Method of preventing or limiting reperfusion damage
11/14/2002	WO2002090339A1 A process for preparing 1-methyl-3-phenyl-piperazine
11/14/2002	WO2002089804A1 Alpha-2-adrenergic agonist/fatty acid compositions
11/14/2002	WO2002089738A2 Proteomimetic compounds and methods
11/14/2002	US20020169318 Novel thrombin inhibitors
11/14/2002	US20020169172 Phenyl or naphthyl-pyrazine compounds useful in the treatment of central nervous system diseases
11/14/2002	US20020169157 An aromatic or heteroaromatic amino acid derivative, used for treating disorders related to overexpression of protein tyrosine phosphatase-1B
11/14/2002	CA2446380A1 Proteomimetic compounds and methods
11/14/2002	CA2446234A1 Alpha-2-adrenergic agonist/fatty acid compositions
11/13/2002	EP1256576A1 Fused imidazolium derivatives
11/13/2002	EP1255741A2 2- 1H]-QUINOLONE AND 2- 1H]-QUINOXALONE INHIBITORS OF FACTOR Xa
11/13/2002	EP1255740A2 Substituted arylpyrazines
11/13/2002	EP1255736A2 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp)
11/13/2002	EP1255734A1 Isatine derivatives with neurotrophic activity
11/13/2002	EP1255726A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/12/2002	US6479662 Antitumor dibenzofluorene derivatives
11/12/2002	US6479608 Heterocyclic alkoxyamines as regulators in controlled radical polymerization processes
11/12/2002	US6479507 Modulation of these inflammatory cytokines is considered one of the most effective strategies to block chronic inflammation and have positive therapeutic outcomes
11/12/2002	US6479492 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/12/2002	US6479485 Benzamidine derivatives and their use as anti-coagulants
11/07/2002	WO2002088274A1 Double-spiro organic compounds and electroluminescent devices
11/07/2002	WO2002088115A1 Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same
11/07/2002	WO2002088101A2 Inhibitors of bace
11/07/2002	WO2002088084A1 Heterocyclic compound derivatives and medicines
11/07/2002	WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002	WO2002056827A3 Substituted felbamate derived compounds
11/07/2002	US20020165264 Aminal diones as potassium channel openers
11/07/2002	US20020165239 Conjugates of sodium channel blockers and methods of using the same
11/07/2002	US20020165230 Gamma-ketoacid dipeptides as inhibitors of caspase-3
11/07/2002	US20020165203 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents
11/07/2002	US20020164577 Detection of transmembrane potentials by optical methods
11/06/2002	EP1254899A2 Piperazine derivatives and their use as anti-inflammatory agents
11/06/2002	EP1254895A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
11/06/2002	EP1253924A1 Nitrate salts of antimicrobial agents
11/05/2002	US6476063 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/05/2002	US6475509 Covalent conjugates of sodium channel blockers and active compounds
10/2002
10/31/2002	WO2002085925A2 Melanocortin receptor ligands
10/31/2002	WO2002069895A3 Heterocyclic analgesic compounds and methods of use thereof
10/31/2002	US20020161234 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde
10/31/2002	US20020158255 Compounds of the general formula P1-L-P2; wherein "P1" is a pyrazinoylguanidine sodium channel blocker, "L" is a linking group, and "P2" is either (i) a pyrazinoylguanidine sodium channel blocker or (ii) a P2Y2 receptor agonist, are disclosed
10/31/2002	CA2444599A1 Melanocortin receptor ligands
10/30/2002	EP1252154A1 Heterocyclic amide derivatives
10/30/2002	EP1252146A1 Amide compounds for inhibiting protein kinases
10/30/2002	EP0805803B1 Process for the production of 1,4,5,6-tetrahydropyrazine-2-carboxylic acid amides
10/30/2002	CN1377336A Carboxylic acid derivatives and drugs containing the same
10/29/2002	US6472529 Viricides
10/29/2002	US6472412 Compounds as PDE IV and TNF inhibitors
10/29/2002	US6472388 Psychotherapeutic agents.
10/24/2002	WO2002083662A2 Azo compounds and process of producing the same and novel intermediate compounds used in the process of producing azo compounds
10/24/2002	WO2002083643A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
10/24/2002	WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
10/24/2002	WO2002083622A2 Novel aminophenyl ketone derivatives
10/24/2002	WO2002083138A1 Inhibitors of akt activity
10/24/2002	WO2002083064A2 A method of treating cancer
10/24/2002	WO2002030931A3 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
10/24/2002	US20020156212 Catalyst systems of alpha -diimine, urethane or urea ligands complexed to nickel, palladium or other transition metals
10/24/2002	US20020155470 Intercalation compound for use in the diagnosis and detection of genetic disorders
10/24/2002	CA2443699A1 Phenyl heterocyclyl ether
10/24/2002	CA2442264A1 A method of treating cancer
10/23/2002	EP1250332A1 Inhibitors of interleukin 5 gene expression
10/23/2002	EP1196384A4 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
10/23/2002	CN1376153A Amide compounds
10/23/2002	CN1376145A A meta-nitro phenol derivative and a process for producing it
10/23/2002	CN1093123C Aralkyl and aralkylidene heterocyclic lactams and imides
10/22/2002	US6469056 Pharmaceutically active compounds, their preparation and use as ECE-inhibitors
10/22/2002	US6469047 Tyrosine derivatives
10/22/2002	US6469039 Benzimidazoles; thrombin- inhibiting activity and the effect of extending thrombin time
10/22/2002	US6469004 Benzoheterocycles and their uses as MEK inhibitors
10/17/2002	WO2002081461A1 Piperazine derivatives as tachykinin antagonists
10/17/2002	WO2002081435A1 Sulphones which modulate the action of gamma secretase
10/17/2002	WO2002080928A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/17/2002	WO2002080921A1 Composition for inhibiting hiv activity extracted from paecilomyces sp. (tochu-kaso) j300
10/17/2002	US20020151566 Phosphodiesterase 4 inhibitors
10/17/2002	US20020151531 Administering to a female of child bearing age over a period of 28 consecutive days a first phase of from 18 to 21 daily dosage units of a progestational agent, and a second phase of from 1 to 7 daily dosage units of an antiprogestin agent
10/17/2002	CA2443108A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/16/2002	EP1249233A1 Npyy5 antagonists
10/16/2002	CN1374954A New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents cnotaining these compounds
10/15/2002	US6465494 Methods for treatment of cystic fibrosis
10/15/2002	US6465467 Diseases related to the 5-ht2c receptor, especially eating, memory, mood, urinary and anxiety disorders, schizophrenia, pain, sexual dysfunctions
10/15/2002	US6465459 Inhibit the enzyme, factor xa
10/15/2002	US6465457 Carbonate, carbamate, thiocarbonate dithiocarbonate and thiocarbomate derivatives useful as fungicides
10/15/2002	US6465433 Boronic ester and acid compounds, synthesis and uses

1 ... 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 ... 187